A prospective and randomized study of radiotherapy, sequential chemotherapy radiotherapy and concomitant chemo therapy-radiotherapy in unresectable non small cell carcinoma of the lung

Journal of Cancer Research and Therapeutics

Volumn 2, Issue 2, 2006, Pages 47-51

  Dasgupta, Anirban ^a,b   Dasgupta, Chandan ^a   Basu, Siddhartha ^a   Majumdar, Anup ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE   (India)

Author keywords

Acute toxicities; Concurrent response; Disease free survival; Metastasis; Neoadjuvant; Non small cell lung cancer

Indexed keywords

EID: 33745262064     PISSN: 09731482     EISSN: 09731482     Source Type: Journal    
DOI: 10.4103/0973-1482.25849     Document Type: Article

References (20)

1. th ed. Mcgraw-Hill: 1998. p. 552-61.
2. Downey RJ, Martin N, Rusch VW. Extent of chest wall invasion and survival in patients of lung cancer. Ann Thorac Surg 1996;68:188-202.
3. Perez CA, Pajak TF, Rubin P. Long term observations of patterns of failure in unresectable NSCLC's treated with definitive radiation. Cancer 1987;59:1874-81.
4. Marino P, Preatoni A, Cantonia. A randomized trial of radiation alone and combined chemo-radiotherapy in stage III A & B NSCLC's Cancer 1995;76:593-9.
5. Cox JD, Axarnia N, Byhardt RW. A randomized trial with hyperfractionated radiation with total dose of 60 Gy to 79.2 Gy in Stage III NSCLC's RTOG 83 -11. J. Clin Oncol 1990;8:1543-55.
6. Hazuka MB, Turisi AT, Lutzs T. High dose thoracic radiation using beam's eye view in NSCLC's. Int J Raiat Biol Physics 1993;27:273-84.
7. Sunderrs M, Dische S, Bariet A. Continuous hyper-fractionated accelerated radiation versus conventional radiation in NSCLC's. Lancet 1997;350:161-5.
8. Dillmanro, Seagren SL, Propert KJ. Improved survival of Stage III NSCLC's seven year follow-up of CALGB -8433 TRIAL. J. Nat Cancer Inst 1996;88:1210-6.
9. Trovo MG, Minatel E, Veronest A. Combined chemo-radiotherapy and radiation alone in advanced NSCLC's. Cancer 1990;65:400-4.
10. Johnson DH, Einhorn LH, Bartolucci A. Thoracic radiation does not prolong survival in patients with advanced NSCLc'S. Ann Int Med 1998;113:32-6.
11. Le Chevaliert, Arriagada R, Quoix E. Radiotherapy alone versus combined chemo-radiotherapy in unresectable NSCLC's J. Nt Cancer Inst 1991:83:417-23.
12. Schakke-Konning, Vander Bogaert, Dalesio O. Effects of concomitant cisplatin and radiation in locally advanced NSCLC's. N Eng J Med 1992;326:524-30.
13. Choy H, Aerley W, Devore R. Weekly paclitaxel and radiation for locally advanced NSCLC'S. Proc Ann Soc Clin Oncol 1996;15:371-5.
14. Belani CP, Aisner J, Day R. Weekly paclitaxel and carboplatin with radiation in locally advanced NSCLC's. Proc Ann Soc Clin Oncol 1998;17:448-56.
15. Furusek, Fukuoka M, Takaday. Phase III study of concurrent and sequential chemoradiotherapy in unresectable NSCLC's. J Clin Oncol 1999;18:458-62.
16. Calmon G, Herndon J, Cooper R. Radiosensitisation with carboplatin in Stage III NSCLC's. J Clin Oncol 1999;17:4-8.
17. Loe JS, Scott C, Komaki R. Concurrent chemoradiation with oral etoposide and cisplatin for inoperable NSCLC's. J Clin Oncol 1996;14:1055-9.
18. Socinski M, Rosenman J, Halle J. Dose escalating conformal radiation with concurrent carboplatin, paclitaxel in advance NSCLC's. Cancer 2001;92:1213-23.
19. Albain KS, Crowley JJ, Turissi AT. Concomitant cisplatin and etoposide with radiation for Stage III B, NSCLC's. Proc Ann Soc Clin Oncol 1997;16:446-52.
20. Reboul F, Brewery, Vincent P. Concomitant chemo-radiotherap0y with cisplatin and etoposide in advanced NSCLC's. Cancer 1997;1:292-9.